We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 51

Eli Lilly Canada Inc. v. Apotex; application to declare NOA null and void
  • Gowling Lafleur Henderson LLP
  • Canada
  • November 2 2009

Apotex sent a NOA regarding the validity of a patent list on the Patent Register for an orally disintegrating tablet form of a drug


Sanofi-Aventis v. Novopharm; preliminary questions regarding costs assessment
  • Gowling Lafleur Henderson LLP
  • Canada
  • November 2 2009

Sanofi had brought a proceeding against Novopharm and joined Schering as the respondentpatentee pursuant to the NOC Regulations


Janssen-Ortho v. Apotex; interlocutory motion for reply evidence; methylphenidate
  • Gowling Lafleur Henderson LLP
  • Canada
  • February 12 2010

In two NOC proceedings, the order of evidence was reversed


Epicept v. Minister of Health; interlocutory motion for confidentiality; histamine
  • Gowling Lafleur Henderson LLP
  • Canada
  • February 12 2010

Epicept has filed for a judicial review of the Minister's decision that its histamine dihydrochloride product is not an innovative drug and is thus not eligible for listing on the register of innovative drugs


Janssen-Ortho v. Novopharm; merits of 55.2 proceeding; methylphenidate
  • Gowling Lafleur Henderson LLP
  • Canada
  • February 12 2010

The only issue in this proceeding was an allegation of non-infringement and the application for prohibition was dismissed


Mycogen v. Bayer and Monsanto; motion for summary judgment
  • Gowling Lafleur Henderson LLP
  • Canada
  • February 12 2010

Bayer brought a motion for summary judgment on the basis that Monsanto had missed the time set out by the Commissioner under section 43 of the Patent Act to respond to the conflict proceeding


Aventis v. Pharmascience; motion to set aside a previous order of prohibition; 2009 FC 915; ramipril; September 15, 2009
  • Gowling Lafleur Henderson LLP
  • Canada
  • September 30 2009

Pharmascience had previously sent an Notice of Allegation (NOA) with respect to a patent to Aventis, resulting in a full hearing and appeal, concluding with an order of prohibition


Janssen-Ortho v. Apotex; motion for a stay; 2009 FCA 250; tramadol and acetaminophen; August 20, 2009
  • Gowling Lafleur Henderson LLP
  • Canada
  • September 30 2009

In the Courts below, Apotex brought a motion to dismiss the application


Sanofi v. Hospira, merits of a 55.2 proceeding
  • Gowling Lafleur Henderson LLP
  • Canada
  • December 3 2009

The Court refused to grant an Order of Prohibition against Hospira regarding its docetaxel product


Pfizer v. ratiopharm, motion to amended a previous judgment on the merits
  • Gowling Lafleur Henderson LLP
  • Canada
  • December 3 2009

ratiopharm was successful in the proceeding under the NOC Regulations at the trial level, but the decision was overturned on appeal